AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Synergistic Gut-brain Axis Modulation Via Vagal Stimulation and Support Therapy in Functional Dyspepsia

RecruitingNAAges 18 Years - 65 YearsAllSpaulding Rehabilitation Hospital
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The study aims at evaluating physiological and patient-reported outcomes for a dual intervention approach including a stimulation device and support therapy in patients with functional dyspepsia.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: Age 18-65 years old (inclusive) * Ability to give written consent and participate in behavioral intervention in English * Willingness to attend weekly treatment sessions over live video, daily self-administered transcutaneous auricular vagus nerve stimulation (taVNS) sessions, and engage in homework during treatment * Avoidance of alcohol, nicotine, and caffeine for 24 hours prior to study session * Diagnosis according to the Rome IV criteria for both epigastric pain syndrome and postprandial distress syndrome subtypes * Stable medical treatment for functional dyspepsia (FD) during 1 month before the study and during the study period Exclusion Criteria: * Previous receipt of cognitive behavioral therapy (CBT) for gastrointestinal symptoms * Enteral or parenteral feeding * Previous gastrointestinal surgery, electrolyte disturbances, kidney dysfunction, renal insufficiency, or iron overload disorders * Estimated Glomerular Filtration Rate (eGFR) \< 60 * Medications that affect gastrointestinal motility in addition to medications or products containing tetrahydrocannabinol (THC) will be stopped at least 7 days prior to the start of the study and for the duration of the study. However, anti-depressants (SSRI's, TCA's) may be allowed in order to reduce the risk of worsening neuropsychiatric disease, though it will be up to the study team and the Principal Investigator whether subjects on anti-depressants will be able to participate in the study * Intellectual disability by history * Diabetes, mitochondrial disease, severe autonomic dysfunction, and small fiber polyneuropathy * No active clinical acupuncture therapy * Illicit drugs or opioid usage * History of arrhythmias * Current pregnancy/breastfeeding * Contraindications for magnetic resonance imaging (MRI) (implanted ferromagnetic objects, claustrophobia) * Weight \> 450 lbs. (limit of the MRI table) * Allergy to pineapple (used in the test meal during MRI) * Any other condition interfering with study requirements, according to the Investigator
๐Ÿ’Š

What it tests

  • Sensory device
  • Skills Building
  • Health Education
  • Subsensory device
๐Ÿ“

Where

1 site
Massachusetts General Hospital
Boston, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy